Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis
Anette H.H. van Boxel-Dezaire(Vrije Universiteit Amsterdam), Lex Nagelkerken(Leiden University Medical Center), Bob W. van Oosten(Amsterdam Neuroscience), A. M. Dräger(Vrije Universiteit Amsterdam), Hans C. van Houwelingen(Leiden University), Frederik Barkhof(National Hospital for Neurology and Neurosurgery), Sabine Hoff(Boston Children's Hospital), H.J. Adèr(University of Amsterdam), C. L. Verweij(Leiden University Medical Center), Chris H. Polman(Vrije Universiteit Amsterdam)
Cited by 267
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis
|Annals of Neurology|2001|7k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k